ENGLISH ABSTRACT
JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

[The role of apolipoprotein E in the pathogenesis of Alzheimer disease].

Alzheimer disease (AD) is by far the most common cause of dementia in humans. Massive accumulation of senile plaques and neurofibrillary tangles are characteristic neuropathological manifestations of the disease. Recent investigations have revealed the presence of apolipoprotein E (apoE) in these structures. Furthermore, APOE4, a specific allele of the apoE gene, is frequently associated with sporadic AD and late-onset familial AD. Now, APOE4 has been established as being a major risk factor for AD. Although apoE is one of numerous plasma lipoproteins, it is of particular interest because, unlike other lipoproteins that are mainly synthesized in the liver, apoE is also synthesized in astrocytes and oligodendrocytes in the central nervous system. Furthermore, apoE plays an important role in the regeneration and degeneration of neurons. Recent studies have indicated the possibility that APOE4 accelerates the deposition of amyloid beta protein, which is a major component of senile plaques in AD brains.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app